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Impaired lysosomal processing of b2-microglobulin by infil- are positive for Congo red staining, showing green bire-
trating macrophages in dialysis amyloidosis. fringence under polarized light and fibrillar appearance
Background. Macrophages may participate in amyloid fibril by electron microscope analysis [1]. Although amyloidformation by processing the protein precursor. Although this
deposition has been classically considered extracellulartheory seems to apply for amyloidosis, in which proteolytic
cleavage is a prerequisite for amyloid fibril formation, it has [1], a few studies showing intracellular amyloid fibrils
not been demonstrated for b2-microglobulin (b2m) amyloidosis. have been reported [2–6]. In some of these amyloidoses,
We aimed to establish the role played by macrophages in b2m it has been suggested that the cells participate in amyloidamyloidosis.
fibril formation by processing the precursor protein [1].Methods. We used a double immunogold electron micros-
Recently, the unprocessed protein precursor, serumcopy technique, including mouse antihuman CD68, rabbit anti-
human b2m, amyloid P component, and lysosome-associated amyloid A (AA), and the proteolyzed protein, AA, have
membrane protein (LAMP-1) antibodies. Differential density been found within the lysosomes in AA amyloidosis [7].labeling studies of b2m and amyloid P component were per- Because AA fibrils contain proteolyzed amyloid protein,formed extra- and intracellularly to assess protein processing
it has been suggested that intralysosomal proteolysisby macrophages.
Results. The cells surrounding amyloid fibrils were found to would be a prerequisite for amyloid fibril formation [7].
be mostly CD68 positive, suggesting that they were of mono- However, the possibility exists that intralysosomal amy-cyte–macrophage lineage. Intracellular accumulation of amy-
loid fibrils were the product of phagocytosis. Althoughloid fibrils was also observed; these fibrils were constantly sur-
most of the reports dealing with the monocytic involve-rounded by LAMP-1–linked gold particles, demonstrating that
intracellular b2m was almost exclusively lysosomal. The rough- ment in the pathogenesis of amyloidosis propose an ac-
surface endoplasmic reticulum was not labeled by b2m anti- tive participation in the formation and subsequent shed-
body, suggesting that there was no active synthesis of b2m by ding of amyloid fibrils by these cells, there are nothe cells. As a marker of endocytosis, protruded cytoplasmic
conclusive studies allowing the rejection of the hypothe-processes in close relation with the intracellular accumulations
of b2m amyloid fibrils were observed. No difference in density sis of a simple phagocytosis of already formed amyloid
labeling (extracellular vs. intracellular) was observed for b2m, fibrils. If the latter were true, the macrophage participa-
whereas intracellular P component labeling was significantly
tion would be part of the reactive phenomena commonlydecreased.
seen in other inflammatory processes rather than theConclusions. All of these data are strongly suggestive of
phagocytosis and not synthesis of amyloid fibrils by macro- cause of amyloidosis.
phages. Further, they demonstrate an impaired lysosomal pro- Dialysis-related amyloidosis (DRA), described in the
cessing specific for b2m, as other compounds of the amyloid 1980s, is a type of amyloidosis with a clear predilectionfibrils (P component) are significantly cleared.
for osteoarticular structures, which is mainly observed
in long-term dialysis patients [8, 9]. Carpal tunnel syn-
drome, scapulohumeral periarthritis, and pain are theAmyloidosis is a disease characterized by the tissue
main clinical features [9, 10]. Biochemically, the maindeposition of insoluble protein fibrils. Amyloid deposits
protein component of DRA fibrils has been identified
as b2-microglobulin (b2m) [11]. The mechanisms byKey words: amyloid fibrils, phagocytosis, dialysis-related amyloidosis,
toxicity. which b2m precipitates into amyloid fibrils remain un-
clear.Received for publication May 5, 1998
Although the protein constituents of DRA have beenand in revised form September 10, 1998
Accepted for publication September 25, 1998 well assessed, the cellular participation on the genesis
of the amyloid fibrils has been less investigated. Only 1999 by the International Society of Nephrology
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a few reports have characterized the cells surrounding ded in Lowicryl K4M (Chemische Werke Lowi, Wald-
Kraiburg, Germany) as previously described [14]. Ul-amyloid deposits in DRA [3, 5, 12], and it is not known
if the presence of these cells is at the origin of the amyloid trathin sections (60 to 90 nm) were obtained using an
Ultracut E system (Reichert-Jung, Wien, Austria) andfibrils or if they accumulate in amyloid deposits because
of the existence of amyloid fibrils. Our aim in this study were mounted on formvar-coated and etched gold grids.
Before labeling, sections were rinsed twice with 0.1 mwas to clarify the cellular participation on the pathogene-
sis of b2m amyloidosis. We performed electron micros- glycine-PBS for five minutes and were incubated with
2% ovalbumin in PBS for 30 minutes to block unspecificcopy studies with simple and/or double immunogold
labeling, as well as with differential density labeling quan- antibody–antigen complexes. The grids were then incu-
bated with polyclonal anti-b2m (dilution 1:500; Nordic,titation. These techniques allowed us to assess the struc-
tural relations between amyloid deposits and the sur- Tilburg, The Netherlands) or anti-amyloid P component
(Dako, Glostrup, Denmark) antibodies in ovalbumin-rounding cells. Furthermore, by identifying the cytosolic
endomembranes and locating the intracellular b2m, we PBS for two hours. After three 15-minute rinses in glycine-
PBS, bound antibodies were visualized with 10 nm pro-were able to hypothesize on the participation of the
cellular organelles (those related with synthesis as well tein A gold (provided by Dr. J.W. Slot, University of
Utrecht, Utrecht, The Netherlands). The sections wereas those related with the degradative pathways) on the
pathogenesis of amyloidosis. Finally, the intracellular finally rinsed with PBS and were double distilled in water
prior to counterstaining with aqueous uranyl acetate andand extracellular behavior of b2m was compared with
those of other constituents of amyloid deposits, such as lead citrate.
Double immunolabeling. For double immunolabe-the amyloid P component, to know whether these pro-
teins are handled differently by the incriminated cells. ling, the samples were fixed as for single labeling, cryo-
protected by infusing 2.1 m sucrose in PBS, snap freezing,
and storing in liquid nitrogen until analysis. Ultrathin
METHODS
cryosections were obtained using an FC-40 cryosystem
Patients and samples (Reichert-Jung) and transferred to formvar-coated and
etched gold grids in a drop of 2.3 m sucrose in PBS.Amyloid deposits were obtained from carpal tunnel
of three men and one woman, who were 65 6 4 years Before labeling, sections were rinsed twice with 0.1 m
glycine-PBS for 10 minutes and were incubated with 2%old, and had dialysis-related amyloidosis. Their renal
diseases were chronic glomerulonephritis (three pa- ovalbumin in PBS for 20 minutes. For immunolabeling,
sections were first incubated with anti-b2-microglobulintients) and autosomal-dominant polycystic renal disease
(the remaining one). None of the patients had systemic antibodies for 30 minutes and were labeled with 15 nm
protein A gold after three glycine-PBS rinses. Then thediseases known to be associated with amyloidosis.
sections were stabilized for five minutes with 0.5% glu-
Sample preparation and immunohistochemistry taraldehyde in PBS, blocked with 150 mm NH4Cl in PBS,
and incubated with a rabbit anti-human lysosome-associ-Congo red staining. Unfixed amyloid deposits surgi-
cally obtained were immersed in O.C.T. compound ated membrane protein (LAMP-1) antibody (dilution
1:120; provided by Dr. S.R. Carlsson, University of Umea,(Miles Inc., Diagnostics Division, Elkhart, IN, USA),
frozen, and stored at 2708C. Cryostat sections of 10 mm Umea, Sweden) or monoclonal anti-CD68 antibody (di-
lution 1:100; Dako) followed by unlabeled rabbit anti-were transferred onto gelatin-coated (0.3%) glass slides
and were stained with Congo red (Searle Scientific Ser- mouse Ig (dilution 1:50; Dako). The ultrathin sections
were rinsed with PBS and double-distilled water, werevices, High Wycombe Bucks, UK) following a slight
modification of Puchtler’s method [13]. Briefly, sections then counterstained with uranyl acetate, and were em-
bedded in methyl cellulose [15].were dehydrated in 70% ethanol for five minutes and
were then treated with an alkaline-saturated salt solu- Controls were performed with the omission of the pri-
mary and/or the secondary antibodies, and/or the omissiontion. The stained sections were mounted in a medium
compatible with organic solvents and were observed un- of the rabbit antimouse Ig. Examination was performed
in a Hitachi H-600 AB and a Philips EM-300 transmis-der polarized light in a Zeiss microscope (Oberkochen,
Germany). sion electron microscopes.
Immunogold methods. Blocks of approximately 1 mm3
Morphology studiesof amyloid deposits were fixed in 4% (vol/vol) paraform-
aldehyde and 0.1% (vol/vol) glutaraldehyde in 0.1 m Semithin sections of 1 mm were obtained from small
blocks of amyloid deposits embedded in Lowicryl K4Mphosphate-buffered saline (PBS), pH 7.4, for two hours
at 48C. resin. Sections were transferred onto glass slides and were
stained with 0.5% methylene blue 0.5% Borax for 30Single immunolabeling. Samples were progressively
dehydrated in graded ethanols and were finally embed- seconds at 908C. The stained sections were then mounted
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in DPX medium and were observed in a Polyvar 2 optical pathways of cells (endoplasmic reticulum or the Golgi
compartment; Fig. 3b).microscope (Reichert-Jung) under immersion oil.
For ultrastructural studies, small pieces of amyloid Two series of studies of double immunolabeling were
performed using the LAMP-1 or KP1 in addition to b2mdeposits were fixed as for Lowicryl embedding and were
postfixed in 2.5% glutaraldehyde (vol/vol) in PBS. Then and amyloid P component antibodies, to characterize the
cytoplasmic membranes containing amyloid fibrils. Whenthe samples were progressively treated in graded ace-
tone-resin solutions, postfixed with 0.1% osmium tetrox- anti-b2m antibody was incubated along with a polyclonal
antihuman LAMP-1 antibody (lysosome marker), bothide, and embedded in Spurr (Agar Scientific LTD,
Stansted, UK). Ultrathin sections were obtained as for antibodies colocalized on the same vesicular structures
(Fig. 3c). Some vesicles labeled with anti-b2m antibodyLowicryl embedded samples using an Ultracut E system
and were then counterstained with uranyl acetate and were only weakly labeled with LAMP-1 antibody. Accord-
ing to their location (marginal, close to the plasma mem-lead citrate before examination in the transmission elec-
tron microscope. brane) and to their immunolabeling pattern (near con-
stant LAMP-1 label), these vesicles had an endocytic
Quantitative evaluation of labeling density character (that is, early endosomes or endocytic vesicles;
Fig. 3c).Label density was estimated as the number of gold
particles per area of amyloid deposit by stereological When anti-b2m antibody was incubated along with
KP1 antibody, their labeling again colocalized withinmethods [16]. Differences were checked using the Stu-
dent’s t-test. A P of less than 0.05 was considered signifi- the same vesicles. Because KP1 antibody is a lysosomal
marker specific for monocytes/macrophages that is di-cant.
rected against the CD68 antigen, these experiments con-
firmed both the lysosomal character of the vesicles con-
RESULTS
taining amyloid fibrils and the monocyte–macrophage
Amyloid diagnosis lineage of the cells associated with the amyloid deposits.
The surgically obtained deposits were of amyloid ori-
Density labeling of b2m and amyloid P componentgin, as they were positively stained with Congo red and
displayed apple-green birefringence under polarized The presence of numerous lysosomes filled with b2m
light. An example of Congo red staining without and with fibrils suggests a failure in degrading the engulfed mate-
polarized light is given in Figure 1 A and B, respectively. rial by the macrophages. To verify this hypothesis, differ-
ential density labeling studies between intracellular and
Deposits and related cells extracellular material were performed for b2m. Further-
Amyloid deposits were observed as nodules, consisting more, the same studies were performed assessing the
of intercellular amorphous material and long-shaped extracellular and intracellular density labeling of amy-
cells as well as macrophages. The long-shaped cells con- loid P component. Amyloid P component is a common
tained in the nodules presented an enlarged perinuclear constituent of most types of amyloidoses, irrespective of
region with long and narrow cytoplasmic processes ex- the characteristics of their major protein component.
tending to the amyloid material (Figure 2). Electron Extracellular density labeling for b2m was not signifi-
microscopy showed that the extracellular material had cantly different from the intracellular one (Fig. 4 a, b).
a heterogeneous composition consisting of amyloid On the contrary, extracellular density labeling for amy-
clumps and some scattered collagen fibers. The macro- loid P component was significantly stronger than the
phage-like cells had an irregular surface with numerous intracellular one (Fig. 4 c, d), suggesting that the engulfed
invaginations that were usually occupied by the amyloid amyloid P component is processed by the cells, whereas
clumps (Fig. 2 a, b). The cytoplasm had a granular ap- there is no cellular processing of b2m. The analysis of
pearance and showed a well-developed Golgi compart- the density labeling is summarized in Table 1.
ment, endoplasmic reticulum, and vesicle compartments.
The vesicles seemed generated by endocytosis of the
DISCUSSIONfibrillar clumps (Fig. 2c). The extracellular amyloid clumps
Our study shows, by immunogold labeling, that mostwere heavily labeled with anti-b2m antibody (Fig. 2b).
of the cells around and between b2m amyloid depositsAmyloid fibrils immunoreactive for anti-b2m antibody
were monocyte–macrophages, presenting cytoplasmicwere also observed within the cytoplasm of macrophage-
extension processes surrounding extracellular b2m fibrils.like cells. These intracellular fibrils were usually con-
Some cells, also positive for macrophage markers, con-tained in vesicles, and cytoplasmic amyloid clumps were
tained intracellular b2m amyloid fibrils. Double immuno-seldom devoid of membrane (Figs. 2c and 3). Intracellu-
gold labeling allowed us for the first time to localizelar labeling of b2m was clearly not associated with the
compartments related to the synthesis and secretory precisely intracellular b2m fibrils within the lysosomes:
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Fig. 1. Amyloid criteria: Congo red staining
of a b2-microglobulin amyloid deposit ob-
served under light microscopy (A) and under
polarized light (B). The publication of this
figure in color was made possible by a grant
from Gambro Renal Care R&D, Lund,
Sweden.
LAMP-1 antibody was distributed on and underneath surrounding the amyloid deposits [12]. However, there
were no previous immunohistochemical studies at thethe membranes of the vesicles containing b2m amyloid
fibrils. These results were fully confirmed by KP1 anti- ultrastructural level confirming the identity of the cells.
Because in most of the different amyloidoses the amy-body immunostaining. Finally, and more importantly,
the analysis of differential density labeling of b2m and loid proteins result from partial proteolytic digestion of
their precursors, proteolysis has been considered for aamyloid P component showed that monocyte–macro-
phage cells are unable to degrade b2m once it is in the long time as a prerequisite for amyloid fibril formation
[1]. Because monocytes and macrophages are enrichedlysosomes and that this impaired lysosomal function is
specific for b2m. in lysosomal structures that may proteolyze the different
amyloid precursors, these cells have been thought to beThe studies aiming to characterize the cells participat-
ing in amyloid formation and/or persistence resulted in responsible for the amyloid fibril formation [1, 2, 4, 19–
21]. However, the opposite may also hold true, and mac-the identification of a variety of cells with a common
feature: their monocyte–macrophage lineage [2, 5, 12, 17, rophages could participate in the reaction processes of
amyloidosis by trying to remove the amyloid fibrils as18]. We have previously established, by specific antigen
typing, the frequency of the different leukocyte cell types they clear other exogenous or endogenous material [22,
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Fig. 2. Amyloid deposit location and b2-
microglobulin distribution. (Inset) Methylene
blue staining showing the cell distribution
around the amyloid fibrils. (a) Electron mi-
croscopy showing a cell engulfing an amyloid
deposit (short thick arrows). Cellular pro-
cesses are indicated by thin arrows (318,000).
Immunogold labeling with anti-b2-microglob-
ulin antibody showing an extracellular (b) and
intracellular (c) location of an amyloid deposit
(327,000).
23]. If this were the case, extracellular amyloid deposi- [28]. Finally, atrial natriuretic factor is frequently found
in intact form in amyloid fibrils of the senile type oftion would take place when the rate of amyloid produc-
tion overcomes the clearing capacity of macrophages. amyloidosis [29].
Our findings are very much supportive of a phagocyto-Interestingly, there are a few exceptions to the proteol-
ysis rule in amyloidosis. The first known exception has sis role for monocyte macrophages and render less likely
the participation of these cells in the synthesis of amyloidbeen b2m amyloidosis. Although a few reports suggest
that the amyloidogenic b2m may be proteolyzed in its fibrils. (a) We found the extracellular amyloid fibrils
frequently surrounded by cellular extensions at differentN-terminal side [24], several groups have shown that the
amyloid deposits in b2m amyloidosis are mainly consti- stages of endocytosis. (b) We observed intracellular b2m
unevenly distributed and located the amyloid fibrilstuted of intact b2m [25, 26]. Other examples of unproteo-
lyzed precursor proteins have been reported subse- within the lysosomes, and (c) we observed no label for
b2m in the synthesis pathways of the cells.quently by Buxbaun for the AL type of amyloidosis [27]
and by Ericsson et al for the AA type of amyloidosis Because the amyloidogenic b2m is intact in its N-termi-
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Fig. 3. Intracellular immunolocalization of
b2-microglobulin. No labeling with anti-b2-
microglobulin antibody was observed in en-
doplasmic reticulum (er) (a, 333,000) nor in
the Golgi compartment (g) (b, 333,000). (c)
Double immunolabeling for 32-microglobu-
lin (15 nm) and lysosome-associated protein
(LAMP-1; 10 nm) showing that amyloid fibrils
are within the lysosomes (340,000). (d) Dou-
ble immunolabeling for b2-microglobulin (15
nm) and CD68 (10 nm) confirming that amy-
loid fibrils are within the lysosomes and that
the cells involved are of macrophage-mono-
cytic lineage (340,000).
nal side, it seems unlikely that macrophages with lyso- ger RNA of amyloid protein precursor (APP) has been
found by in situ hybridization in plaque-associated micro-somes filled with b2m participate in synthesis of amyloid
fibrils. glia, suggesting no synthesis of the amyloid precursor [34].
Once the ultrastructural studies enabled us to con-A second line of evidence supporting the phagocytic
role for the cells surrounding amyloid fibrils comes from clude that amyloid fibrils are contained in lysosomes, we
aimed to step further and assessed the degradation ofAlzheimer’s disease. Cataldo et al reported the up-regu-
lation of cathepsin D synthesis and the accumulation of the different proteins of these amyloid fibrils. We com-
pared the density labeling of the extracellular amyloidhydrolase-laden lysosomes in pyramidal neurons, indi-
cating that the endosomal-lysosomal system is abnor- fibrils in regard to the intracellular ones. It came out
clearly from our studies that macrophages were able tomally activated in Alzheimer’s disease [30]. On the other
hand, the addition of inhibitors of lysosomal proteinases degrade the amyloid P component through phagocytosis
and lysosomal processing. On the contrary, b2m, afterdoes not block the formation of amyloid fibrils in the in
vitro setting [31–33]. In other words, the endosomal- being internalized by the same cells, was not processed
further. Therefore, the lysosomes of macrophages werelysosomal system is activated, but its blockade does not
result in preventing the formation of amyloid fibrils. unable to pursue the processing of b2m. Whether the
lack of processing of b2m is due to the conformationalThus, such activation would be a consequence rather
than the cause of amyloid fibril formation. In keeping situation of the molecule within amyloid fibrils or to an
intrinsic characteristic of b2m is not known. Very re-with the phagocytic hypothesis, no detection of messen-
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Fig. 4. Density labeling studies of b2-micro-
globulin and amyloid P component (APC):
Comparison of intracellular and extracellular
protein density. It can be observed that extra-
cellular labeling of b2-microglobulin (a,
327,000) was similar to that observed intracel-
lularly (b, 327,000), whereas a clear decrease
in intracellular APC labeling (d, 333,000) was
observed when comparing with extracellular
APC labeling (c 337,800).
Table 1. Intracellular and extracellular density labeling with anti- degradation. Whether the accumulated b2m behaves like
b2-microglobulin and anti-amyloid P substance antibodies
a cell toxin remains to be demonstrated.
Extracellular Intracellular In summary, although the biochemical analysis of the
different types of amyloidosis is quite well established,b2-microglobulin 299 6 53 266 6 53 (NS)
Amyloid P substance 12 6 1 5 6 1a the cellular participation has been less assessed. There
Values represent the mean 6 standard error fo the mean of the patients. The is some controversy as to whether the cells surrounding
value for each patient was obtained by averaging 5 random readings of 3 different the amyloid deposits synthesize the amyloid fibrils ortissue preparations.
P , 0.001 (Student’s T test intracellular versus extracellular) are there to degrade them. Previous studies on AL and
AA amyloidoses suggested a synthesis role. Our analysis
of b2m amyloid deposits showed that the phagocytic cells
frequently observed in amyloid deposits have cytoplas-
cently, Inoue et al have nicely shown the arrangement mic extension processes in regards to the b2m amyloid
of b2m, amyloid P component, and chondroitin sulfate fibril-enriched zones. Further, it showed that the intracel-
proteoglycan within amyloid fibrils [35]. According to lular b2m is preferentially and almost exclusively intraly-
these elegant ultrastructural studies, b2m is associated sosomal, and there were no signs of synthesis of b2m or
with the surface of the amyloid fibrils [35] and would be amyloid fibrils. We have previously reported the identi-
accessible to lysosomal proteases. Therefore, the struc- fication of the major serum antiprotease a2-macroglobu-
ture of b2m, comprising of two b-pleated sheets of three lin in b2m amyloid deposits [36] and proposed a role for
antiproteases in the pathogenesis of amyloidosis [37].and four strands, respectively, may render it resistant to
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J: Cells surrounding haemodialysis-associated amyloid deposits areThese data represent an extension from the protein to
mainly macrophages. Nephrol Dial Transplant 9:662–667, 1994
the cellular level on the assessment of the catabolism of 13. Putchler H, Sweat F, Levine M: Binding of Congo Red by amy-
loid. J Histochem Cytochem 10:355–364, 1962amyloid fibrils. We hypothesize that failure of lysosomes
14. Carlemaln E, Garavito RM, Villiger W: Resin developmentto degrade intact b2m may be one of the key points for electron microscopy and an analysis of embedding at low tem-
in the pathogenesis of b2m amyloidosis. Our data are perature. J Microsc 126:123–143, 1982
15. Tokuyasu KT: Immunocytochemistry on ultrathin sections. Histo-supportive of a phagocytic role for macrophages and
chem J 12:381–403, 1980provide some evidence that lysosomal function is not
16. Weibel ER: Stereological methods, in Practical Methods for Bio-
effective in processing and clearing b2m, suggesting a logical Morphometry, New York, Academic Press, 1979
17. Kisilevsky R, Lyon AW, Young I: A critical analysis of postulatedputative b2m toxicity on these cells.
pathogenetic mechanisms in amyloidogenesis. Crit Rev Clin Lab
Sci 29:59–82, 1992
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